Product Images Dutasteride
View Photos of Packaging, Labels & Appearance
- Dutasteride structural formula - dutasteride capsules 1
- Figure 1. AUA-SI Score* Change from Baseline (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - dutasteride capsules 2
- Figure 2. Percent of Subjects Developing Acute Urinary Retention Over a 24-Month Period (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - dutasteride capsules 3
- Figure 3. Percent of Subjects Having Surgery for Benign Prostatic Hyperplasia Over a 24-Month Period (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - dutasteride capsules 4
- Figure 4. Prostate Volume Percent Change from Baseline (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - dutasteride capsules 5
- Figure 5. Qmax Change from Baseline (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - dutasteride capsules 6
- 1968f777-figure-07 - dutasteride capsules 7
- Figure 7. Qmax Change from Baseline (CombAT study) - dutasteride capsules 8
- 71205-039-90 - dutasteride capsules 9
Product Label Images
The following 9 images provide visual information about the product associated with Dutasteride NDC 71205-039 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Dutasteride structural formula - dutasteride capsules 1
Figure 1. AUA-SI Score* Change from Baseline (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - dutasteride capsules 2
Figure 2. Percent of Subjects Developing Acute Urinary Retention Over a 24-Month Period (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - dutasteride capsules 3
Figure 3. Percent of Subjects Having Surgery for Benign Prostatic Hyperplasia Over a 24-Month Period (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - dutasteride capsules 4
Figure 4. Prostate Volume Percent Change from Baseline (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - dutasteride capsules 5
Figure 5. Qmax Change from Baseline (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - dutasteride capsules 6
1968f777-figure-07 - dutasteride capsules 7
Figure 7. Qmax Change from Baseline (CombAT study) - dutasteride capsules 8
71205-039-90 - dutasteride capsules 9
This is a medication bottle of Dutasteride capsules, each containing 0.5mg of the active ingredient. The bottle contains 90 capsules and has a lot number, batch number, and expiration date. The capsules are opaque, yellow, oblong, and imprinted with 'A 75'. The medicine is prescribed and is distributed only on RX. The manufacturer and distributor of the medicine are Amneal Pharmaceuticals Bridgewater in NJ, USA. The medicine bottle has a warning to read the manufacturer's warning information. The lot number is identified as SD003990. The medicine is stored in a temperature range of 20°C to 25°C and should be kept out of reach of children. The NDC number of the medicine is 71205-039-90. The bottle also shows that some of the capsules have been relabeled by Proficient Rx LP in Thousand Oaks, CA 91320.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
